Medicare Enrolled

Amy Lankford, FNP

Pain Medicine · North Wilkesboro, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1103 W D ST, North Wilkesboro, NC 28659
3368830029
Registered in NPPES since 2019
NPI: 1134776214 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Lankford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Lankford? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Lankford

Amy Lankford is a pain medicine specialist in North Wilkesboro, NC, with 7 years of NPI registration. Based on federal Medicare data, Lankford performed 1,215 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Lankford received a total of $1,910 from 33 pharmaceutical and/or device companies across 117 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Lankford is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years of NPI registration ▲ Top 47% volume in NC $1,910 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,215
Medicare services
Top 47% in NC for pain medicine
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
237 $60 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
223 $74 $226
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
204 $0 $1
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
127 $48 $156
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
68 $12 $28
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
67 $112 $217
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
61 $8 $37
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
25 $10 $18
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
25 $8 $14
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
19 $13 $28
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
18 $8 $11
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
18 $20 $85
Annual intensive behavioral therapy for cardiovascular disease, 15 minutes
A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually.
18 $21 $49
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
17 $29 $61
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
17 $40 $85
Annual alcohol misuse screening, 5 to 15 minutes 17 $15 $35
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
15 $10 $18
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
13 $9 $16
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
13 $16 $30
Total T3 thyroid hormone test
A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels.
13 $14 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,910
Total received (2021-2024)
Avg $477/year across 4 years
Bottom 49% in NC for pain medicine
33
Companies
117
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$562
2023
$499
2022
$511
2021
$338

Payments by company (2024)

ABBVIE INC.
$208
Novo Nordisk Inc
$50
Forte Bio-Pharma LLC
$38
Otsuka America Pharmaceutical, Inc.
$34
GlaxoSmithKline, LLC.
$33
Bayer Healthcare Pharmaceuticals Inc.
$29
Braeburn Inc.
$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
Collegium Pharmaceutical, Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
Lilly USA, LLC
$17
PFIZER INC.
$16
SHIELD THERAPEUTICS INC
$15
Paratek Pharmaceuticals, Inc.
$15
Exact Sciences Corporation
$14
AstraZeneca Pharmaceuticals LP
$13
Top 3 companies account for 52.8% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$492
GlaxoSmithKline, LLC.
$155
Novo Nordisk Inc
$139
USWM, LLC
$123
Forte Bio-Pharma LLC
$115
FORTE BIO-PHARMA LLC
$74
Indivior Inc.
$67
ITI, Inc.
$64
AbbVie Inc.
$58
Otsuka America Pharmaceutical, Inc.
$50
Currax Pharmaceuticals LLC
$50
Scilex Pharmaceuticals Inc.
$50
IDORSIA PHARMACEUTICALS US INC
$49
Lilly USA, LLC
$31
PFIZER INC.
$30
Amgen Inc.
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
AstraZeneca Pharmaceuticals LP
$27
Braeburn Inc.
$27
SCILEX PHARMACEUTICALS INC.
$26
Biohaven Pharmaceuticals, Inc.
$25
Amarin Pharma Inc.
$22
Biohaven Pharmaceutical Holding Company Ltd.
$21
Novartis Pharmaceuticals Corporation
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
Collegium Pharmaceutical, Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
SHIELD THERAPEUTICS INC
$15
Paratek Pharmaceuticals, Inc.
$15
Gilead Sciences, Inc.
$14
Exact Sciences Corporation
$14
Kowa Pharmaceuticals America, Inc.
$13
BioDelivery Sciences International, Inc.
$13
Top 3 companies account for 41.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ANORO ELLIPTA · BELBUCA · BREZTRI · BRIXADI · Belbuca · CAPLYTA · CREON · Cologuard Collection Kit · EMGALITY · ENTRESTO · FARXIGA · Kerendia · LINZESS · Lucemyra · MAVYRET · MOUNJARO · NALOCET · NEXLETOL · NURTEC ODT · NUZYRA · Otezla · Ozempic · PROLATE · QULIPTA · QUVIVIQ · REXULTI · Rybelsus · SEGLENTIS · SUBLOCADE · TRELEGY ELLIPTA · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Wegovy · ZIMHI · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pain medicine specialist in North Wilkesboro?
Compare pain medicines in the North Wilkesboro area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines in nearby ZIP areas
4
County median income
$50,438
Nearest hospital to ZIP centroid (approximate)
WILKES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Lankford is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Lankford experienced with drug screening test?
Based on Medicare claims data, Lankford performed 237 drug screening test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Lankford receive payments from pharmaceutical companies?
Yes. Lankford received a total of $1,910 from 33 companies across 117 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Lankford's costs compare to other pain medicines in North Wilkesboro?
Lankford's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Lankford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →